We sought to use three different antibodies (IgA, IgM, and IgG) to minimize bias and ensure the different proposed interpretations, such as diagnosis, potential subclinical infection, contact with M. leprae, and patients already treated for HD. Here, CD79A is linked to Huntington disease.